Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
NCT: NCT05295615 · RECRUITING
Brief Summary
An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment.
Frequently Asked Questions
What is Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease?
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease is a clinical trial registered under NCT05295615. Current status: RECRUITING.
What is the status of NCT05295615?
The current status of NCT05295615 (Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease) is: RECRUITING.
When did Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease start?
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease started on 2023-05-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.